Synendos Therapeutics CHF 20m Series A Financing: the advisor
Walder Wyss advised the investors co-led by Kurma Partners and Sunstone Life Science Ventures on the CHF 20m series A financing of Synendos Therapeutics.
Walder Wyss advised the investors co-led by Kurma Partners and Sunstone Life Science Ventures on the CHF 20m series A financing of Synendos Therapeutics.